Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo

Gilbert J. L'Italien, Daniel E. Casey, Hong J. Kan, William H. Carson, Ronald N. Marcus

Research output: Contribution to journalArticlepeer-review

62 Scopus citations

Fingerprint

Dive into the research topics of 'Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo'. Together they form a unique fingerprint.

Medicine & Life Sciences